Oppenhoff advises tesa SE on the acquisition of tesa Labtec GmbH by Adhex Pharma

Oppenhoff advised tesa SE on the sale of tesa Labtec GmbH, a specialty pharmaceutical contract development and manufacturing organization for transdermal therapeutic systems and oral films, to Adhex Pharma.

Adhex Pharma is a pharmaceutical company specialized in the field of development and manufacturing of transdermal patches, oral thin films and hard-to-make dosage forms. It is headquartered in Paris and part of Burgundy Ventures, an independent French industrial holding.

The Oppenhoff team led by Dr. Markus Rasner included Moritz Schmitz (M&A, Healthcare), Till Liebau, Marcel Markovic (both M&A), Dr. Marc Hilber, Patrick Schwarze (both IT&C), Anja Dombrowsky, Cornelia-Cristina Scupra (both Employment), Peter Klappich (Healthcare), Dr. Wolfgang Kotzur (Finance), Dr. Simon Spangler, Dr. Daniel Dohrn (both Antitrust) and Dr. Gunnar Knorr (Tax).

Oppenhoff regularly advises companies from the healthcare sector, most recently on the sale of the MVZ Nephrologicum Westfalen, Shop Apotheke on the acquisition of Smartpatient or the acquisition of the CNP Group by capiton.

Back to list